What is he best known for?
The fields of study he is best known for:
His main research concerns Biochemistry, Steroid, Receptor, Internal medicine and Endocrinology.
His studies in Tyrosine aminotransferase, Tyrosine, Enzyme, Cysteine synthase and Cysteine are all subfields of Biochemistry research.
Gordon M. Tomkins performs multidisciplinary studies into Steroid and Tissue culture in his work.
He interconnects Cytoplasm and Cytoplasmic receptor in the investigation of issues within Receptor.
His studies in Internal medicine integrate themes in fields like Molecular biology, Protein biosynthesis, Enzyme synthesis and Cell culture.
His work on Hydrocortisone as part of general Endocrinology research is frequently linked to Mechanism, bridging the gap between disciplines.
His most cited work include:
- Glucocorticoid receptors: relations between steroid binding and biological effects. (508 citations)
- Control of Specific Gene Expression in Higher Organisms (464 citations)
- Induction of tyrosine alpha-ketoglutarate transaminase by steroid hormones in a newly established tissue culture cell line. (390 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Biochemistry, Tyrosine aminotransferase, Molecular biology, Enzyme and Endocrinology.
His Biochemistry study is mostly concerned with Steroid, Tyrosine Transaminase, Messenger RNA, RNA and Ribosome.
His research investigates the connection between Tyrosine aminotransferase and topics such as Enzyme inducer that intersect with problems in Mitosis.
His research in Molecular biology intersects with topics in Cell culture, Protein kinase A and Dexamethasone.
The study incorporates disciplines such as Chromatography and lac operon, Escherichia coli in addition to Enzyme.
His research integrates issues of Receptor, Internal medicine and Lymphoma in his study of Endocrinology.
He most often published in these fields:
- Biochemistry (55.91%)
- Tyrosine aminotransferase (29.92%)
- Molecular biology (25.98%)
What were the highlights of his more recent work (between 1974-2016)?
- Biochemistry (55.91%)
- Molecular biology (25.98%)
- Endocrinology (22.83%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Biochemistry, Molecular biology, Endocrinology, Internal medicine and Glucocorticoid receptor.
His research on Biochemistry frequently connects to adjacent areas such as Cholera toxin.
Gordon M. Tomkins has included themes like RNA, Tyrosine aminotransferase and Enzyme in his Molecular biology study.
His Tyrosine aminotransferase study integrates concerns from other disciplines, such as Messenger RNA and Intracellular.
Dexamethasone, Steroid and Hormone are subfields of Endocrinology in which his conducts study.
His study in Steroid is interdisciplinary in nature, drawing from both Tyrosine, Insulin and Cytoplasm.
Between 1974 and 2016, his most popular works were:
- Selection of a variant lymphoma cell deficient in adenylate cyclase (247 citations)
- Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action (218 citations)
- The metabolic code. (202 citations)
In his most recent research, the most cited papers focused on:
Gordon M. Tomkins mainly focuses on Biochemistry, Cytosol, Glucocorticoid receptor, Molecular biology and DNA.
Enzyme inducer, Mitogen-activated protein kinase kinase, Phosphodiesterase, Cyclic AMP receptors and Cell are the primary areas of interest in his Biochemistry study.
The Cytosol study combines topics in areas such as Chromatin, Histone, Macromolecule and Adenosine.
His Glucocorticoid receptor study is associated with Endocrinology.
His Molecular biology research is multidisciplinary, incorporating perspectives in Mutation, Germline mutation, Somatic cell, Mutant and Kinase.
His DNA research incorporates elements of Bacteriophage and Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
